MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Cancer Research
Mengyu XieAmer A Beg

Abstract

Activating mutations in BRAF, a key mediator of RAS signaling, are present in approximately 50% of melanoma patients. Pharmacologic inhibition of BRAF or the downstream MAP kinase MEK is highly effective in treating BRAF-mutant melanoma. In contrast, RAS pathway inhibitors have been less effective in treating epithelial malignancies, such as lung cancer. Here, we show that treatment of melanoma patients with BRAF and MEK inhibitors (MEKi) activated tumor NF-κB activity. MEKi potentiated the response to TNFα, a potent activator of NF-κB. In both melanoma and lung cancer cells, MEKi increased cell-surface expression of TNFα receptor 1 (TNFR1), which enhanced NF-κB activation and augmented expression of genes regulated by TNFα and IFNγ. Screening of 289 targeted agents for the ability to increase TNFα and IFNγ target gene expression demonstrated that this was a general activity of inhibitors of MEK and ERK kinases. Treatment with MEKi led to acquisition of a novel vulnerability to TNFα and IFNγ-induced apoptosis in lung cancer cells that were refractory to MEKi killing and augmented cell-cycle arrest. Abolishing the expression of TNFR1 on lung cancer cells impaired the antitumor efficacy of MEKi, whereas the administration of TNFα...Continue Reading

References

Mar 10, 2006·Pigment Cell Research·Yukiko Ueda, Ann Richmond
May 18, 2011·Molecular and Cellular Biology·Roshan J ThapaSiddharth Balachandran
Jun 4, 2011·Biochemical Pharmacology·Inna V FedorenkoKeiran S M Smalley
Dec 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin B KimKarl D Lewis
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Feb 5, 2013·Nature·Heidi BraumüllerMartin Röcken
Apr 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Fang WeiJames L Riley
May 3, 2013·The Journal of Clinical Investigation·Emily L HopewellAmer A Beg
Sep 21, 2013·Nature Immunology·Thomas F GajewskiYang-Xin Fu
Feb 4, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·James S WilmottGeorgina V Long
May 21, 2014·Nature Reviews. Clinical Oncology·Yujie Zhao, Alex A Adjei
Jun 7, 2014·Cancer Immunology Research·Zachary A CooperJennifer A Wargo
Sep 5, 2014·Cancer Immunology Research·Yifeng XiaInder M Verma
Jan 23, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hojabr KakavandRichard A Scolyer
Feb 24, 2015·The Journal of Clinical Investigation·Lawrence N KwongLynda Chin
Feb 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G R BlumenscheinP A Jänne
Mar 20, 2015·Science Translational Medicine·Siwen Hu-LieskovanAntoni Ribas
Apr 8, 2015·Cancer Discovery·Catherine B Meador, William Pao
Jun 4, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D MassiM Mandalà
Mar 12, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hong ZhengAmer A Beg
Jan 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adeeb DerakhshanCarter Van Waes
Mar 18, 2017·Science·Bjoern Papke, Channing J Der
Oct 25, 2017·Nature Communications·Mandar Deepak MuzumdarTyler Jacks
Feb 15, 2018·Cell Reports·Tina L YuanFrank McCormick

❮ Previous
Next ❯

Citations

Nov 28, 2019·Cancer Research·Jonathan J Havel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis